- Home
- GDEN vs CRMD Comparison
GDEN vs CRMD Comparison
Compare GDEN & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDEN
- CRMD
- Stock Information
- Founded
- GDEN 1998
- CRMD 2006
- Country
- GDEN United States
- CRMD United States
- Employees
- GDEN N/A
- CRMD N/A
- Industry
- GDEN Services-Misc. Amusement & Recreation
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- GDEN Consumer Discretionary
- CRMD Health Care
- Exchange
- GDEN Nasdaq
- CRMD Nasdaq
- Market Cap
- GDEN 856.1M
- CRMD 738.4M
- IPO Year
- GDEN 1999
- CRMD 2010
- Fundamental
- Price
- GDEN $33.27
- CRMD $12.49
- Analyst Decision
- GDEN Strong Buy
- CRMD Strong Buy
- Analyst Count
- GDEN 7
- CRMD 6
- Target Price
- GDEN $36.57
- CRMD $15.67
- AVG Volume (30 Days)
- GDEN 202.8K
- CRMD 1.3M
- Earning Date
- GDEN 02-27-2025
- CRMD 03-11-2025
- Dividend Yield
- GDEN 3.10%
- CRMD N/A
- EPS Growth
- GDEN N/A
- CRMD N/A
- EPS
- GDEN 1.27
- CRMD N/A
- Revenue
- GDEN $733,305,000.00
- CRMD $12,262,234.00
- Revenue This Year
- GDEN N/A
- CRMD N/A
- Revenue Next Year
- GDEN $2.03
- CRMD $246.41
- P/E Ratio
- GDEN $26.27
- CRMD N/A
- Revenue Growth
- GDEN N/A
- CRMD 41184.20
- 52 Week Low
- GDEN $27.42
- CRMD $2.89
- 52 Week High
- GDEN $40.55
- CRMD $13.85
- Technical
- Relative Strength Index (RSI)
- GDEN 62.54
- CRMD 70.88
- Support Level
- GDEN $31.49
- CRMD $7.91
- Resistance Level
- GDEN $32.81
- CRMD $13.09
- Average True Range (ATR)
- GDEN 0.84
- CRMD 0.70
- MACD
- GDEN 0.20
- CRMD 0.43
- Stochastic Oscillator
- GDEN 97.30
- CRMD 88.68
About GDEN Golden Entertainment Inc.
Golden Entertainment Inc is a U.S. based company that focuses on distributed gaming, casino, and resort operations. Its reportable segments are Nevada Casino Resorts, Nevada Locals Casinos, Nevada Taverns, and Distributed Gaming. The majority of the revenue for the company is generated from its Nevada Casino Resorts segment which is comprised of destination casino resort properties offering a variety of food and beverage outlets, entertainment venues, and other amenities.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.